ZJYL vs. TMCI, NPCE, OM, CLPT, NNOX, SNWV, ZIMV, DRTS, NYXH, and SKIN
Should you be buying Jin Medical International stock or one of its competitors? The main competitors of Jin Medical International include Treace Medical Concepts (TMCI), NeuroPace (NPCE), Outset Medical (OM), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), Sanuwave Health (SNWV), ZimVie (ZIMV), Alpha Tau Medical (DRTS), Nyxoah (NYXH), and Beauty Health (SKIN). These companies are all part of the "medical equipment" industry.
Jin Medical International vs. Its Competitors
Jin Medical International (NASDAQ:ZJYL) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.
84.1% of Treace Medical Concepts shares are owned by institutional investors. 27.7% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Treace Medical Concepts had 1 more articles in the media than Jin Medical International. MarketBeat recorded 1 mentions for Treace Medical Concepts and 0 mentions for Jin Medical International. Treace Medical Concepts' average media sentiment score of 1.84 beat Jin Medical International's score of 0.00 indicating that Treace Medical Concepts is being referred to more favorably in the news media.
Jin Medical International has a beta of 9.85, indicating that its stock price is 885% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500.
Jin Medical International has higher earnings, but lower revenue than Treace Medical Concepts.
Jin Medical International has a net margin of 0.00% compared to Treace Medical Concepts' net margin of -25.14%. Jin Medical International's return on equity of 0.00% beat Treace Medical Concepts' return on equity.
Treace Medical Concepts has a consensus target price of $10.16, suggesting a potential upside of 67.86%. Given Treace Medical Concepts' stronger consensus rating and higher probable upside, analysts clearly believe Treace Medical Concepts is more favorable than Jin Medical International.
Summary
Treace Medical Concepts beats Jin Medical International on 8 of the 14 factors compared between the two stocks.
Get Jin Medical International News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZJYL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ZJYL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jin Medical International Competitors List
Related Companies and Tools
This page (NASDAQ:ZJYL) was last updated on 7/5/2025 by MarketBeat.com Staff
